IR versus MR [Design Issues]

posted by gagandeep – 2007-03-29 12:58 (7019 d 04:21 ago) – Posting: # 601
Views: 5,621

Dear

I suggest you perform the study by the following method:
  1. See the Tmax, Cmax and half-lives of the drugs
  2. Dose the subjects with the MR and choose timepoints as per Tmax and half-life – Plot the timepoints accordingly (keep frequent timepoints near Tmax)
  3. With the BD drug, again plan timepoints accordingly and keep them frequent near each Tmax.
  4. Remember that the timepoints and consequently blood collection for the subjects randomized into BD dosing will be more. Hence take care not to exceed the total volume of blood collection more than your SOP’s / procedures / IRB recommendations
  5. In case you are doing fast and fed studies and for example, if food delays Tmax or changes the slope of the graph of conc v/s time, then you may have to re-adjust timepoints of in fed study, or even add / subtract a couple timepoints.
  6. Your statistician should be prepared well for such project.
Good luck!

Dr. Gagandeep Singh
Head – Clinical Research
BioArc (Alembic Pharma)

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
132 visitors (0 registered, 132 guests [including 22 identified bots]).
Forum time: 17:19 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5